Clinical Trial Update: INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP [Phase 3]

View source ↗

Summary

Phase 3 trial examining increased sun exposure without pain in participants with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP) has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythropoietic Protoporphyria
• X-linked Protoporphyria

Snippet

Sponsor: Tanabe Pharma America, Inc. | Conditions: Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP) | Phase 3 | Status: COMPLETED